[go: up one dir, main page]

AU2002334097A1 - Application of the crystal structure of nusa in drug discovery - Google Patents

Application of the crystal structure of nusa in drug discovery

Info

Publication number
AU2002334097A1
AU2002334097A1 AU2002334097A AU2002334097A AU2002334097A1 AU 2002334097 A1 AU2002334097 A1 AU 2002334097A1 AU 2002334097 A AU2002334097 A AU 2002334097A AU 2002334097 A AU2002334097 A AU 2002334097A AU 2002334097 A1 AU2002334097 A1 AU 2002334097A1
Authority
AU
Australia
Prior art keywords
nusa
application
crystal structure
drug discovery
discovery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002334097A
Inventor
Kristine Arnvig
Kay COLSTON
Robert A. Cox
Guy Dodson
Balasubramanian Gopal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU2002334097A1 publication Critical patent/AU2002334097A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/30Drug targeting using structural data; Docking or binding prediction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205Phosphotransferases in general
    • G01N2333/91245Nucleotidyltransferases (2.7.7)
    • G01N2333/9125Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Theoretical Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AU2002334097A 2001-10-05 2002-10-04 Application of the crystal structure of nusa in drug discovery Abandoned AU2002334097A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32703201P 2001-10-05 2001-10-05
US60/327,032 2001-10-05
PCT/GB2002/004507 WO2003031986A2 (en) 2001-10-05 2002-10-04 Application of the crystal structure of nusa in drug discovery

Publications (1)

Publication Number Publication Date
AU2002334097A1 true AU2002334097A1 (en) 2003-04-22

Family

ID=23274838

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002334097A Abandoned AU2002334097A1 (en) 2001-10-05 2002-10-04 Application of the crystal structure of nusa in drug discovery

Country Status (2)

Country Link
AU (1) AU2002334097A1 (en)
WO (1) WO2003031986A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156526A (en) * 1998-07-21 2000-12-05 The Rockerfeller University Crystal of a Ras-Sos complex and methods of use thereof
US6225076B1 (en) * 1999-09-15 2001-05-01 The Rockefeller University Crystal of bacterial core RNA polymerase and methods of use thereof

Also Published As

Publication number Publication date
WO2003031986A2 (en) 2003-04-17
WO2003031986A3 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
AU2002341641A1 (en) Crystal structure of interleukin-22 and uses thereof
AUPR535101A0 (en) Novel therapeutic molecules
AU2001268163A1 (en) Haplotypes of the ube3a gene
AU2001253521A1 (en) Haplotypes of the cxcr4 gene
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2002334097A1 (en) Application of the crystal structure of nusa in drug discovery
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III
AU2001261749A1 (en) Crystal structures of p- selectin,ep0105895-selectin complexes, and uses thereof
AU2002215923A1 (en) Use of medicaments
AU2001281123A1 (en) Haplotypes of the isl1 gene
AU6106801A (en) Trans-clitoral administration of therapy
AU2001268324A1 (en) Haplotypes of the cfl1 gene
AU2001276556A1 (en) Novel pharmaceutical use of quinnoline derivatives
AU2001286890A1 (en) Haplotypes of the scya2 gene
AU2002365245A1 (en) Crystal structure of yqej and uses thereof
HK1067372A (en) Crystal structure of baff, and use thereof in drug design
AUPR713201A0 (en) Novel therapeutic molecules and uses therefor
AU2001261373A1 (en) Haplotypes of the gpr4 gene
AU2001280872A1 (en) Protected structure of flat panel display
AU2001264800A1 (en) Haplotypes of the aldh5a1 gene
AU2002256917A1 (en) Liquid drug preparations
AUPR647401A0 (en) Novel therapeutic molecules and uses thereof
AU2002228358A1 (en) Analgesic and antiinflammatory drugs
AUPR496601A0 (en) Therapeutic molecules and methods - 3

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase